Unknown

Dataset Information

0

Targeting Remission in Moderate-to-Severe Crohn's Disease.


ABSTRACT: Therapeutic options in development for the treatment of Crohn's disease represent a broad range of approaches to this complex disease. This active pipeline contains a combination of both small-molecule entities and targeted monoclonal antibodies.

SUBMITTER: Kish T 

PROVIDER: S-EPMC5969213 | biostudies-other | 2018 Jun

REPOSITORIES: biostudies-other

altmetric image

Publications

Targeting Remission in Moderate-to-Severe Crohn's Disease.

Kish Troy T  

P & T : a peer-reviewed journal for formulary management 20180601 6


Therapeutic options in development for the treatment of Crohn's disease represent a broad range of approaches to this complex disease. This active pipeline contains a combination of both small-molecule entities and targeted monoclonal antibodies. ...[more]

Similar Datasets

| S-EPMC8127062 | biostudies-literature
| S-EPMC3186726 | biostudies-literature
| S-EPMC4041179 | biostudies-other
| S-EPMC9274823 | biostudies-literature
| S-EPMC6953260 | biostudies-literature
| S-EPMC7389339 | biostudies-literature
| S-EPMC8342392 | biostudies-literature
| S-EPMC6486011 | biostudies-literature
| S-EPMC6718195 | biostudies-literature
| S-EPMC10658649 | biostudies-literature